1 681 kr
Skickas inom 10-15 vardagar
1 681 kr
Skickas inom 10-15 vardagar
1 123 kr
Skickas inom 10-15 vardagar
1 681 kr
Skickas inom 10-15 vardagar
1 353 kr
Skickas inom 7-10 vardagar
1 577 kr
Läs direkt efter köp
2 371 kr
Skickas inom 3-6 vardagar
1 529 kr
Skickas inom 3-6 vardagar
16 065 kr
Läs direkt efter köp
This encyclopedia advances the understanding of behavioral medicine principles and clinical applications among researchers and practitioners in medicine, psychology, public health, epidemiology, nursing, and social work. In addition, the encyclopedia provides useful synergies for sociologists, anthropologists, and undergraduates with some interest in the interface of human health and behavior.
Areas covered include quality of life and lifespan issues; population, health policy, and advocacy issues; health promotion and disease prevention; behavioral care in all types of settings; biological, psychological, and person factors in health behavior change; professional development and practice-related issues; and much more.
This encyclopedia is the first resource to which readers turn for factual, relevant, and comprehensive information to aid in delivering the highest quality services.
3 651 kr
Skickas inom 7-10 vardagar
4 704 kr
Läs direkt efter köp
561 kr
Skickas inom 10-15 vardagar
750 kr
Läs direkt efter köp
2 110 kr
Läs direkt efter köp
1 668 kr
Skickas inom 10-15 vardagar
1 502 kr
Läs direkt efter köp
1 114 kr
Skickas inom 10-15 vardagar
2 051 kr
Läs direkt efter köp
1 592 kr
Skickas inom 10-15 vardagar
3 661 kr
Skickas inom 7-10 vardagar
1 123 kr
Skickas inom 10-15 vardagar
1 007 kr
Läs direkt efter köp
At a time when the field of cardiac safety is going through important changes, this unique book provides the rationale for, and cutting-edge explanations of, new regulatory landscapes that will likely govern cardiac safety assessments globally for the foreseeable future. Exposure-response modeling is already being accepted by regulatory agencies in lieu of the traditional Thorough QT/QTc Study, and the Comprehensive in vitro Proarrhythmia Assay initiative is well under way.
Developments in the field of cardiovascular safety are also described and discussed in the book. These include the search for more efficient ways to exonerate new drugs for type 2 diabetes from an unacceptable cardiovascular liability, how best to address off-target blood pressure increases induced by noncardiovascular drugs, and the continued evolution of the discipline of Cardio-oncology.“a resource that will likely serve as a standard for years to come”
- Dr Jonathan Seltzer
Therapeutic Innovation & Regulatory Science, 2017;51(2):180
“I have no hesitation in recommending this book as a valuable reference source”
- Dr Rashmi Shah
Journal for Clinical Studies, 2017;9(1):62-63
782 kr
Skickas inom 10-15 vardagar
John Wiley and Sons Ltd
1 224 kr
Tillfälligt slut
576 kr
Tillfälligt slut